Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Providing Care Managers with Patient Medication History Data Could Help Increase Adherence and Save U.S. Healthcare $3.76 Billion

Surescripts®, the nation's leading health information network, projects more than $3.76 billion in savings across healthcare in the U.S. for health plans, employers and patients, when care managers have access to a patient’s medication history, better enabling them to support patients, close gaps in care, and improve Star Ratings.

An analysis conducted by Surescripts examined the cost savings that could be realized if care managers leveraged Surescripts Medication History for Populations technology to simplify the medication review process with dispensed medication data that informs gaps in care and member risk, assesses adherence, reconciles medications and reduces the likelihood of adverse drug events.

The projected savings across stakeholders over the course of three years is significant:

  • Patients: $1.88 billion saved nationwide for patients enrolled in health plans due to lower healthcare spending and fewer workdays missed.
  • Employers: $1.23 billion saved in reduced healthcare spending in addition to greater employee productivity and from fewer days missed at work.
  • Payers: $648.3 million in estimated savings for U.S. health plan populations, stemming from lower medical costs and higher Star Ratings.

More than a quarter of U.S. adults face multiple common chronic conditions, like diabetes and hypertension, and a population seeing the largest and fastest increase among people ages 65 and older in more than a century, care providers are managing more at-risk patient populations than ever before.

The CDC reports that in the U.S., nearly seven in 10 adults aged 40–79 used at least one prescription drug in the past 30 days and more than one in five used at least five prescription drugs in that timeframe.

“Technology that provides clinicians and care managers with visibility into a patient’s medications can help tackle one of the costliest challenges in healthcare – helping patients, especially those with chronic conditions, get the routine care they need to manage and avoid more serious, costlier care events,” said Dr. Lynne Nowak, Chief Data & Analytics Officer for Surescripts. “Given how often medications are part of a patient’s care plan, Innovations that help care providers get on the same page with access to timely, complete and accurate patient medication information can meaningfully improve adherence, support safer prescribing and deliver overall better quality, less costly care for patients.”

For several years, provider organizations have been using Surescripts Medication History for Populations to make their care management programs more efficient. Patient data that once took a full month to reach them now arrives in one to three days.

“The ability to access complete medication history for all partners supporting a patient’s care but is especially critical to reducing risks for those patients with multiple chronic conditions like diabetes and hypertension,” said Tara Dragert, Chief Product Officer for Surescripts. “When care teams have the full, up-to-date picture of their patient's medication histories, they can better support and close gaps in their care with targeted interventions and meaningful medication management support between provider visits. Having this information can also mean more successful value-based care programs and most importantly, improved care outcomes for patients.”

Health plans experience member turnover at the new year and throughout the year, which means they have very little data—or none—on new-to-plan members, making it more difficult to identify higher-risk members. This technology provides access to this information, helping care managers identify patients who may benefit from additional outreach and support in chronic disease management programs.

About the analysis: Projections of future experience based on reasonable assumptions. The assumptions used in the modeling of prepared scenarios are reasonable, both individually and in aggregate. Results may vary from these projections based on the emergence of actual experience.

About Surescripts

Our purpose is to serve the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and ensure quality care. At Surescripts, we align healthcare organizations across the nation and convene the Surescripts Network Alliance® to give healthcare professionals the trusted insights they need to serve patients. Together, we're bringing more intelligence to prescribing, informing treatment and care management with interoperability, and making it simpler to handle benefits and authorizations so patients get high-quality, affordable care sooner. Visit us at surescripts.com and follow us on LinkedIn.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.